• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由葡萄球菌抑制剂稳定的替代补体途径C3转化酶的结构和功能意义

Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.

作者信息

Rooijakkers Suzan H M, Wu Jin, Ruyken Maartje, van Domselaar Robert, Planken Karel L, Tzekou Apostolia, Ricklin Daniel, Lambris John D, Janssen Bert J C, van Strijp Jos A G, Gros Piet

机构信息

Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Nat Immunol. 2009 Jul;10(7):721-7. doi: 10.1038/ni.1756. Epub 2009 Jun 7.

DOI:10.1038/ni.1756
PMID:19503103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2729104/
Abstract

Activation of the complement system generates potent chemoattractants and leads to the opsonization of cells for immune clearance. Short-lived protease complexes cleave complement component C3 into anaphylatoxin C3a and opsonin C3b. Here we report the crystal structure of the C3 convertase formed by C3b and the protease fragment Bb, which was stabilized by the bacterial immune-evasion protein SCIN. The data suggest that the proteolytic specificity and activity depend on the formation of dimers of C3 with C3b of the convertase. SCIN blocked the formation of a productive enzyme-substrate complex. Irreversible dissociation of the complex of C3b and Bb is crucial to complement regulation and was determined by slow binding kinetics of the Mg(2+)-adhesion site in Bb. Understanding the mechanistic basis of the central complement-activation step and microbial immune evasion strategies targeting this step will aid in the development of complement therapeutics.

摘要

补体系统的激活会产生强效趋化因子,并导致细胞被调理以进行免疫清除。寿命短暂的蛋白酶复合物将补体成分C3裂解为过敏毒素C3a和调理素C3b。我们在此报告由C3b和蛋白酶片段Bb形成的C3转化酶的晶体结构,该结构由细菌免疫逃避蛋白SCIN稳定。数据表明,蛋白水解特异性和活性取决于C3与转化酶的C3b形成二聚体。SCIN阻断了有活性的酶-底物复合物的形成。C3b和Bb复合物的不可逆解离对补体调节至关重要,并且由Bb中Mg(2+)结合位点的缓慢结合动力学决定。了解补体激活核心步骤的机制基础以及针对该步骤的微生物免疫逃避策略将有助于补体疗法的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/6a6eb6249b5e/nihms-118073-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/310d08870fc7/nihms-118073-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/45be610436ae/nihms-118073-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/e8a67372ef82/nihms-118073-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/e64cbfa4fe90/nihms-118073-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/6a6eb6249b5e/nihms-118073-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/310d08870fc7/nihms-118073-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/45be610436ae/nihms-118073-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/e8a67372ef82/nihms-118073-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/e64cbfa4fe90/nihms-118073-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f9/2729104/6a6eb6249b5e/nihms-118073-f0006.jpg

相似文献

1
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.由葡萄球菌抑制剂稳定的替代补体途径C3转化酶的结构和功能意义
Nat Immunol. 2009 Jul;10(7):721-7. doi: 10.1038/ni.1756. Epub 2009 Jun 7.
2
A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.结构动态的 N 端螺旋是葡萄球菌补体抑制剂 (SCIN) 蛋白的关键功能决定因素。
J Biol Chem. 2013 Jan 25;288(4):2870-81. doi: 10.1074/jbc.M112.426858. Epub 2012 Dec 11.
3
Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.通过对与 C3c 和 C3b 结合的葡萄球菌补体抑制剂(SCIN)的晶体结构研究确定补体识别和抑制的分子基础。
J Mol Biol. 2010 Sep 10;402(1):17-29. doi: 10.1016/j.jmb.2010.07.029. Epub 2010 Jul 21.
4
Allosteric inhibition of complement function by a staphylococcal immune evasion protein.金黄色葡萄球菌免疫逃逸蛋白对补体功能的别构抑制。
Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17621-6. doi: 10.1073/pnas.1003750107. Epub 2010 Sep 27.
5
A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.对葡萄球菌补体抑制蛋白家族逃避补体机制的分子洞察。
J Immunol. 2009 Aug 15;183(4):2565-74. doi: 10.4049/jimmunol.0901443. Epub 2009 Jul 22.
6
Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.补体因子B工程化Bb片段的结构分析:对替代途径C3转化酶激活机制的深入了解
Mol Cell. 2004 Apr 9;14(1):17-28. doi: 10.1016/s1097-2765(04)00160-1.
7
Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein family.葡萄球菌补体抑制剂(SCIN)蛋白家族 C3b [更正]接触残基和三级结构的多样性。
J Biol Chem. 2012 Jan 2;287(1):628-640. doi: 10.1074/jbc.M111.298984. Epub 2011 Nov 15.
8
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.一种作用于C3转化酶的葡萄球菌补体抑制剂介导的免疫逃逸
Nat Immunol. 2005 Sep;6(9):920-7. doi: 10.1038/ni1235. Epub 2005 Aug 7.
9
Structures of C3b in complex with factors B and D give insight into complement convertase formation.C3b 与因子 B 和 D 复合物的结构为补体转化酶形成提供了深入了解。
Science. 2010 Dec 24;330(6012):1816-20. doi: 10.1126/science.1195821.
10
Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.基于金黄色葡萄球菌SCIN蛋白鉴定替代补体途径的肽类抑制剂。
Mol Immunol. 2015 Oct;67(2 Pt B):193-205. doi: 10.1016/j.molimm.2015.05.012. Epub 2015 Jun 4.

引用本文的文献

1
Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment.耐甲氧西林和敏感金黄色葡萄球菌:耐受性、免疫逃避与治疗
Nat Rev Microbiol. 2025 Aug 20. doi: 10.1038/s41579-025-01226-2.
2
Acquired drivers of C3 glomerulopathy.C3肾小球病的后天性驱动因素。
Clin Kidney J. 2025 Jan 27;18(3):sfaf022. doi: 10.1093/ckj/sfaf022. eCollection 2025 Mar.
3
Immunity and Coagulation in COVID-19.新型冠状病毒肺炎中的免疫与凝血。

本文引用的文献

1
Phaser crystallographic software.相位结晶学软件。
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. doi: 10.1107/S0021889807021206. Epub 2007 Jul 13.
2
Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complement.一种选择性抑制补体替代途径的C3b特异性抗体的结构与功能分析
J Biol Chem. 2009 Apr 17;284(16):10473-9. doi: 10.1074/jbc.M809106200. Epub 2009 Feb 5.
3
3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
Int J Mol Sci. 2024 Oct 19;25(20):11267. doi: 10.3390/ijms252011267.
4
Complement C3 deposition restricts the proliferation of internalized by promoting autophagy.补体 C3 沉积通过促进自噬来限制内化 的增殖。
Front Cell Infect Microbiol. 2024 Sep 6;14:1400068. doi: 10.3389/fcimb.2024.1400068. eCollection 2024.
5
The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation.C1 酯酶抑制剂与 C1s 的米氏复合体的晶体结构揭示了补体调控的新见解。
J Immunol. 2024 Sep 1;213(5):718-729. doi: 10.4049/jimmunol.2400194.
6
Reconstitution of the alternative pathway of the complement system enables rapid delineation of the mechanism of action of novel inhibitors.补体系统替代途径的重建使得新型抑制剂作用机制的快速阐明成为可能。
J Biol Chem. 2024 Jul;300(7):107467. doi: 10.1016/j.jbc.2024.107467. Epub 2024 Jun 12.
7
Mechanism of complement inhibition by a mosquito protein revealed through cryo-EM.通过冷冻电镜揭示了蚊子蛋白对补体的抑制机制。
Commun Biol. 2024 May 27;7(1):649. doi: 10.1038/s42003-024-06351-x.
8
Molecular mechanism of complement inhibition by the trypanosome receptor ISG65.锥虫受体ISG65抑制补体的分子机制
Elife. 2024 Apr 24;12:RP88960. doi: 10.7554/eLife.88960.
9
A guide to complement biology, pathology and therapeutic opportunity.补体生物学、病理学与治疗机会指南
Nat Rev Immunol. 2024 Feb;24(2):118-141. doi: 10.1038/s41577-023-00926-1. Epub 2023 Sep 5.
10
A Monoclonal Antibody That Provides a Model for C3 Nephritic Factors.一种提供 C3 肾炎因子模型的单克隆抗体。
Monoclon Antib Immunodiagn Immunother. 2023 Feb;42(1):9-14. doi: 10.1089/mab.2022.0028.
C3bB复合物的三维结构为补体替代途径转化酶的激活和调节提供了见解。
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):882-7. doi: 10.1073/pnas.0810860106. Epub 2009 Jan 9.
4
Structure of and influence of a tick complement inhibitor on human complement component 5.蜱补体抑制剂对人补体成分5的结构及影响
Nat Immunol. 2008 Jul;9(7):753-60. doi: 10.1038/ni.1625. Epub 2008 Jun 8.
5
Complement evasion by human pathogens.人类病原体的补体逃避
Nat Rev Microbiol. 2008 Feb;6(2):132-42. doi: 10.1038/nrmicro1824.
6
Complement driven by conformational changes.由构象变化驱动的补体。
Nat Rev Immunol. 2008 Jan;8(1):48-58. doi: 10.1038/nri2231.
7
The initiating proteases of the complement system: controlling the cleavage.补体系统的起始蛋白酶:控制裂解过程
Biochimie. 2008 Feb;90(2):387-95. doi: 10.1016/j.biochi.2007.07.023. Epub 2007 Aug 6.
8
Staphylococcal complement inhibitor: structure and active sites.葡萄球菌补体抑制剂:结构与活性位点
J Immunol. 2007 Sep 1;179(5):2989-98. doi: 10.4049/jimmunol.179.5.2989.
9
Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition.与补体成分C3c结合的补体抑制素结构揭示了补体抑制的新机制。
J Biol Chem. 2007 Oct 5;282(40):29241-7. doi: 10.1074/jbc.M704587200. Epub 2007 Aug 6.
10
Factor B structure provides insights into activation of the central protease of the complement system.B因子结构为深入了解补体系统中心蛋白酶的激活机制提供了线索。
Nat Struct Mol Biol. 2007 Mar;14(3):224-8. doi: 10.1038/nsmb1210. Epub 2007 Feb 25.